Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Tumors that cause bone metastases].

Acta ortopedica mexicana·2021

Same author

[Osteochondromas: introducing the subungual osteochondroma].

Acta ortopedica mexicana·2017

Same author

[Comparative study of the management of congenital brachymetatarsia with elongation with callotaxis].

Acta ortopedica mexicana·2016

Same author

[Utility of morphogenetic protein for the treatment of congenital pseudoarthrosis of the tibia].

Acta ortopedica mexicana·2016

Same author

[Infected pseudoarthrosis of the tibia, a pediatric case. Case report and literature review].

Acta ortopedica mexicana·2013

Same author

[Proximal focal femoral deficiency complicated by a proximal femur fracture].

Acta ortopedica mexicana·2012

Search research articles

Related Experiment Video

Updated: May 23, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

[Multicenter osteoblastic osteosarcoma in a preschooler. Case report].

V Bermúdez-Balbuena¹, A López-Durán, J Shalkow

¹Instituto Nacional de Pediatría. draverobb@hotmail.com

Acta Ortopedica Mexicana

|April 19, 2012

Summary

Osteoblastic osteosarcoma, a common pediatric bone cancer, can present aggressively in very young children. This case highlights a 19-month-old with this rare, aggressive presentation.

More Related Videos

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Related Experiment Videos

Last Updated: May 23, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Area of Science:

Pediatric Oncology
Skeletal Neoplasms
Bone Cancer Research

Background:

Osteoblastic osteosarcoma is the most common primary malignant bone tumor in children, typically affecting adolescents during growth spurts.
While rare, cases in children under 8 years old have been documented, suggesting potential variations in presentation and behavior.
The National Pediatrics Institute has observed only three cases in children under 5 years old over 35 years, underscoring the rarity of early-onset osteosarcoma.

Observation:

This report details a unique case of a 19-month-old male diagnosed with osteoblastic osteosarcoma affecting the left distal femur and proximal tibia.
The tumor presented with multicentric features, an unusual characteristic for osteosarcoma, especially in such a young patient.
The patient's extremely young age at diagnosis is a significant factor distinguishing this case from typical presentations.

Findings:

The early age of onset and multicentric nature of the tumor in this case suggest a potentially more aggressive and rapidly growing form of osteoblastic osteosarcoma.
Comparison with institutional data reveals the extreme rarity of osteosarcoma in patients under 5 years old.
This case challenges the typical age-related presentation patterns for osteoblastic osteosarcoma.

Implications:

The findings suggest that osteoblastic osteosarcoma in very young children may exhibit increased aggressiveness and a faster growth rate.
This case underscores the need for vigilance and potentially tailored treatment approaches for early-onset pediatric osteosarcoma.
Further research into the specific biological and clinical factors driving aggressive osteosarcoma in infants and toddlers is warranted.